Search results
Apple juice lot recalled due to high arsenic levels; product sold at Publix, Kroger, more
USA Today· 4 days agoOne lot of Martinelli’s apple juice is being recalled over concerns with high arsenic levels, the...
Q1 2024 Fulgent Genetics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 hours agoOur BEACON volume has mostly been limited to IVF clinics due to carrier screening, often being coupled with noninvasive prenatal testing or NIPT at the OB/GYN level. However ...
Deal struck on FAA bill
Politico· 5 days agoThe Washington Post. — “Emergency...
BILL Holdings Inc (BILL) (Q3 2024) Earnings Call Transcript High
Guru Focus· 2 days agoBILL's customer base expanded with the addition of 450,000 small businesses using the platform to automate their financial operations, emphasizing strong market adoption.
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 17 hours agoKymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript May 3, 2024 Kymera...
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoGE HealthCare Technologies Inc. (NASDAQ:GEHC) Q1 2024 Earnings Call Transcript April 30, 2024 GE...
Iron Mountain (IRM) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoFinally, a multinational conglomerate company has signed a deal with us to manage its ALM needs for data center decommissioning as well as their end user...
AP Business SummaryBrief at 4:31 p.m. EDT
Bozeman Daily Chronicle· 7 days agoThe United Auto Workers union announced it reached a last-minute tentative agreement with truck and bus manufacturer Daimler Truck on Friday evening, averting a potential ...
Assembly budget leaders might back off expanded sales tax
Richmond Times-Dispatch· 16 hours agoSenate Finance Chair Louise Lucas, D-Portsmouth, and House Appropriations Chairman Luke Torian,...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 days agoGSK aims to tap into the 50-59 age group, which would expand its market potential by an additional 15 million at-risk adults in the U.S., Walmsley says.
